A Study of Tirzepatide in Participants With Impaired Liver Function

I8F-MC-GPGQ -

The purpose of this study is to assess how fast tirzepatide gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants.

Trial Summary

Age Range
18 - 85 years
Conditions the trial is for
Hepatic Insufficiency
What the trial is testing?
Tirzepatide
Could I receive a Placebo?
No
Enrollment Goal
32
Trial Dates
Jul 22, 2019 - Sep 22, 2020
How long will I be in the trial?
The study will last about two months and will include five visits to the study center.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must have a diagnosis of impaired liver function

Participants Must Not:

  • Participants must not be taking blood sugar-lowering drugs, other than metformin

  • Female participants must not be able to get pregnant

  • Participants must not have a personal or family history of thyroid cancer

  • Participants must not have a history of or a diagnosis of disease of the pancreas

  • Participants must not have kidney disease

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.